AAS
GILD icon

Avantax Advisory Services’s Gilead Sciences GILD Stock Holding History

Avantax Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$12M Buy
107,883
+14,034
+15% +$1.49M 0.07% 233
2025
Q1 		$10.5M Sell
93,849
-2,896
-3% -$299K 0.06% 235
2024
Q4 		$8.94M Sell
96,745
-10,184
-10% -$917K 0.06% 256
2024
Q3 		$8.96M Buy
106,929
+9,338
+10% +$713K 0.06% 246
2024
Q2 		$6.7M Buy
97,591
+64,119
+192% +$4.28M 0.05% 293
2024
Q1 		$2.45M Sell
33,472
-3,195
-9% -$246K 0.02% 488
2023
Q4 		$2.97M Sell
36,667
-4,808
-12% -$374K 0.03% 405
2023
Q3 		$3.11M Sell
41,475
-761
-2% -$58.5K 0.03% 351
2023
Q2 		$3.26M Sell
42,236
-2,044
-5% -$163K 0.04% 336
2023
Q1 		$3.67M Buy
44,280
+1,562
+4% +$129K 0.05% 305
2022
Q4 		$3.67M Sell
42,718
-6,625
-13% -$525K 0.05% 283
2022
Q3 		$3.04M Buy
49,343
+7,123
+17% +$449K 0.05% 292
2022
Q2 		$2.61M Buy
42,220
+5,635
+15% +$349K 0.04% 325
2022
Q1 		$2.18M Buy
36,585
+535
+1% +$34.2K 0.03% 356
2021
Q4 		$2.62M Sell
36,050
-243
-0.7% -$16.7K 0.04% 310
2021
Q3 		$2.53M Buy
36,293
+8,575
+31% +$602K 0.04% 299
2021
Q2 		$1.91M Buy
27,718
+4,632
+20% +$309K 0.03% 335
2021
Q1 		$1.49M Buy
23,086
+1,561
+7% +$101K 0.03% 355
2020
Q4 		$1.25M Sell
21,525
-33,768
-61% -$2.04M 0.03% 354
2020
Q3 		$3.48M Buy
55,293
+33,381
+152% +$2.31M 0.06% 257
2020
Q2 		$1.69M Buy
21,912
+6,388
+41% +$490K 0.05% 249
2020
Q1 		$1.16M Buy
15,524
+5,480
+55% +$379K 0.03% 275
2019
Q4 		$650K Sell
10,044
-1,947
-16% -$127K 0.02% 413
2019
Q3 		$758K Buy
11,991
+185
+2% +$12.1K 0.03% 256
2019
Q2 		$798K Sell
11,806
-211
-2% -$13.9K 0.04% 225
2019
Q1 		$781K Buy
12,017
+363
+3% +$24.1K 0.04% 213
2018
Q4 		$729K Buy
+11,654
New +$815K 0.12% 169

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Avantax Advisory Services's GILD Position: Q2 2025 in Review

Avantax Advisory Services increased its Gilead Sciences (GILD) stake by 15% in Q2 2025, buying an estimated $1.49M and bringing the position to 107,883 shares worth $12M. The position accounts for 0.07% of the portfolio, ranked #233.

Avantax Advisory Services first reported a position in GILD in Q4 2018 and has held it in 27 quarters since. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Avantax Advisory Services held 107,883 shares of Gilead Sciences worth $12M as of Q2 2025.
  • Avantax Advisory Services bought 14,034 Gilead Sciences shares in Q2 2025, an estimated $1.49M.
  • Gilead Sciences made up 0.07% of Avantax Advisory Services's portfolio in Q2 2025, its #233 holding.
  • Avantax Advisory Services first reported a position in Gilead Sciences in Q4 2018 and has held it in 27 quarters since.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.